Cancer Home > Neulasta Warnings and Precautions

To help minimize risks, make sure you understand Neulasta warnings and precautions before taking the drug. Prior to using Neulasta, let your healthcare provider know if you have myeloid cancers or precancerous conditions, sickle cell anemia, or any allergies. It is important to know that Neulasta may potentially cause adult respiratory distress syndrome, stimulate the growth of cancer cells, or worsen sickle cell anemia.

Neulasta: What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking Neulasta® (pegfilgrastim) if you have:
 
  • Sickle cell anemia
  • Myeloid cancers or precancerous conditions, such as:
o Acute myelogenous leukemia (AML), also known as chronic myeloid leukemia
o Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia
o Myelodysplastic syndromes (MDS)
o Myeloproliferative disease
  • Any allergies, including allergies to food, dyes, or preservatives.
     
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about all other medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.